Cargando…
Generating evidence for new high-risk medical devices
Autores principales: | Campbell, Bruce, Wilkinson, John, Marlow, Mirella, Sheldon, Murray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647579/ https://www.ncbi.nlm.nih.gov/pubmed/35047781 http://dx.doi.org/10.1136/bmjsit-2019-000022 |
Ejemplares similares
-
IDEAL as a guide to designing clinical device studies consistent with the new European Medical Device Regulation
por: Fleetcroft, Camilla, et al.
Publicado: (2021) -
Long-term active surveillance of implantable medical devices: an analysis of factors determining whether current registries are adequate to expose safety and efficacy problems
por: Banerjee, Samprit, et al.
Publicado: (2019) -
Medical device risk (re)classification: lessons from the FDA’s 515 Program Initiative
por: Mooghali, Maryam, et al.
Publicado: (2023) -
Developing the foundation for assessment of Devices used for Acute Ischemic Stroke Interventions (DAISI) using a Coordinated Registry Network
por: LeRoy, Hartley, et al.
Publicado: (2022) -
Regulatory reliance for convergence and harmonisation in the medical device space in Asia-Pacific
por: Xu, Ming, et al.
Publicado: (2022)